p.54 抽出テキスト

42 DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supra-

ventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med. 1990;113:104–10. 43.	 Bhandari AK, Anderson JL, Gilbert EM, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. Am Heart J. 1992;124:381–6. 44.	 Sintetos AL, Roark SF, Smith MS, et al. Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia. Arch Intern Med. 1986;146:2205–9. 45.	 Henthorn RW, Waldo AL, Anderson JL, et al. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation. 1991;83:119–25. 46.	 Dorian P, Naccarelli GV, Coumel P, et al. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. Am J Cardiol. 1996;77:89A–95A. 47.	 Lu C-W, Wu M-H, Chen H-C, et al. Epidemiological profile of Wolff- Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. Int J Cardiol. 2014;174:530–4. 48.	 Whinnett ZI, Sohaib SMA, Davies DW. Diagnosis and management of supraventricular tachycardia. BMJ. 2012;345:e7769. 49.	 Porter MJ, Morton JB, Denman R, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1:393–6. 50.	 Campbell RW. Supraventricular tachycardia: occasional nuisance or frequent threat? Eur Heart J. 1996; 17 Suppl C:21–5. 51.	 Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20:717–21. 52.	 Goyal R, Zivin A, Souza J, et al. Comparison of the ages of tachycardia onset in patients with atrioventricular nodal reentrant tachycardia and accessory pathway-mediated tachycardia. Am Heart J. 1996;132:765–7. 53.	 Maryniak A, Bielawska A, Bieganowska K, et al. Does atrioventricular reentry tachycardia (AVRT) or atrioventricular nodal reentry tachycardia (AVNRT) in children affect their cognitive and emotional development? Pediatr Cardiol. 2013;34:893–7. 54.	 González-Torrecilla E, Almendral J, Arenal A, et al. Combined evaluation of bedside clinical variables and the electrocardiogram for the differential diagnosis of paroxysmal atrioventricular reciprocating tachycardias in patients without pre-excitation. J Am Coll Cardiol. 2009;53:2353–8. 55.	 Liu S, Yuan S, Hertervig E, et al. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome. J Electrocardiol. 2001;34:295–301. 56.	 Anand RG, Rosenthal GL, Van Hare GF, et al. Is the mechanism of supraventricular tachycardia in pediatrics influenced by age, gender or ethnicity? Congenit Heart Dis. 2009;4:464–8. 57.	 Erdogan A, Schulte B, Carlsson J, et al. [Clinical characteristics of patients with AV-nodal reentrant tachycardia (AVNRT): modification by high frequency catheter ablation. Study of 748 patients after high frequency catheter ablation]. Med Klin (Munich). 2001;96:708–12. 58.	 Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol. 1995;76:675–8. 59.	 Walfridsson U, Strömberg A, Janzon M, et al. Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardia in a Swedish population: consequences on health-related quality of life. Pacing Clin Electrophysiol. 2009;32:1299–306. 60.	 Cain N, Irving C, Webber S, et al. Natural history of Wolff- Parkinson-White syndrome diagnosed in childhood. Am J Cardiol. 2013;112:961–5. 61.	 Lessmeier TJ, Gamperling D, Johnson-Liddon V, et al. Unrecognized paroxysmal supraventricular tachycardia: potential for misdiagnosis as panic disorder. Arch Intern Med. 1997;157:537–43. 62.	 Laurent G, Leong-Poi H, Mangat I, et al. Influence of ventriculoatrial timing on hemodynamics and symptoms during supraventricular tachycardia. J Cardiovasc Electrophysiol. 2009;20:176–81. 63.	 Abe H, Nagatomo T, Kobayashi H, et al. Neurohumoral and hemodynamic

mechanisms of diuresis during atrioventricular nodal reentrant tachycardia. Pacing Clin Electrophysiol. 1997;20:2783–8. 64 Auricchio A, Klein H, Trappe HJ, et al. Lack of prognostic value of

syncope in patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1991;17:152–8. 65.	 Drago F, Turchetta A, Calzolari A, et al. Reciprocating supraventricular tachycardia in children: low rate at rest as a major factor related to propensity to syncope during exercise. Am Heart J. 1996;132:280–5. 66.	 Kalusche D, Ott P, Arentz T, et al. AV nodal re-entry tachycardia in elderly patients: clinical presentation and results of radiofrequency catheter ablation therapy. Coron Artery Dis. 1998;9:359–63. 67.	 Haghjoo M, Arya A, Heidari A, et al. Electrophysiologic characteristics and results of radiofrequency catheter ablation in elderly patients with atrioventricular nodal reentrant tachycardia. J Electrocardiol. 2007;40:208–13. 68.	 Leitch JW, Klein GJ, Yee R, et al. Syncope associated with supraventricular tachycardia: an expression of tachycardia rate or vasomotor response? Circulation. 1992;85:1064–71. 69.	 Razavi M, Luria DM, Jahangir A, et al. Acute blood pressure changes after the onset of atrioventricular nodal reentrant tachycardia: a time-course analysis. J Cardiovasc Electrophysiol. 2005;16:1037–40. 70.	 Sganzerla P, Fabbiocchi F, Grazi S, et al. Electrophysiologic and haemodynamic correlates in supraventricular tachycardia. Eur Heart J. 1989;10:32–9. 71.	 Hamdan MH, Zagrodzky JD, Page RL, et al. Effect of P-wave timing during supraventricular tachycardia on the hemodynamic and sympathetic neural response. Circulation. 2001;103:96–101. 72.	 Walfridsson U, Walfridsson H. The impact of supraventricular tachycardias on driving ability in patients referred for radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2005;28:191–5. 73.	 Brugada P, Brugada J, Mont L, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83:1649–59. 74.	 Vereckei A, Duray G, Szénási G, et al. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89–98. 75.	 Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010;122:S729–67. 76.	 Knight BP, Zivin A, Souza J, et al. Use of adenosine in patients hospitalized in a university medical center. Am J Med. 1998;105:275–80. 77.	 Willems S, Shenasa M, Borggrefe M, et al. Atrioventricular nodal reentry tachycardia: electrophysiologic comparisons in patients with and without 2:1 infra-His block. Clin Cardiol. 1993;16:883–8. 78.	 Pava LF, Perafán P, Badiel M, et al. R-wave peak time at DII: a new criterion for differentiating between wide complex QRS tachycardias. Heart Rhythm. 2010;7:922–6. 79.	 Letsas KP, Weber R, Siklody CH, et al. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway. Acta Cardiol. 2010;65:171–6. 80.	 Knight BP, Ebinger M, Oral H, et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2000;36:574–82. 81.	 Murman DH, McDonald AJ, Pelletier AJ, et al. US emergency department visits for supraventricular tachycardia, 1993–2003. Acad Emerg Med. 2007;14:578–81. 82.	 Lim SH, Anantharaman V, Teo WS, et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med. 1998;31:30–5. 83.	 Luber S, Brady WJ, Joyce T, et al. Paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med. 2001;19:40–2. 84.	 Waxman MB, Wald RW, Sharma AD, et al. Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol. 1980;46:655–64. 85.	 Tavşanoglu S, Ozenel E. Ice-water washcloth rather than facial immersion (diving reflex) for supraventricular tachycardia in adults. Am J Cardiol. 1985;56:1003. 86.	 Wayne MA. Conversion of paroxysmal atrial tachycardia by facial immersion in ice water. JACEP. 1976;5:434–5. 87.	 Brady WJ, DeBehnke DJ, Wickman LL, et al. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil. Acad Emerg Med. 1996;3:574–85. 88.	 Gausche M, Persse DE, Sugarman T, et al. Adenosine for the prehospital

treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1994;24:183–9.

Downloaded from http://ahajournals.org by on October 7, 2026